Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHRISTOPHER G WANG

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1083856157
CMS profile
1304108
Location
BIRMINGHAM, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$4,641.31

171 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,953.52 168
Consulting Fee $1,665.00 1
Education $22.79 2

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
AstraZeneca Pharmaceuticals LP $1,757.78 7
Seagen Inc. $214.20 14
Octapharma USA, Inc. $193.26 1
Novartis Pharmaceuticals Corporation $184.49 10
Amgen Inc. $174.51 11
Takeda Pharmaceuticals U.S.A., Inc. $132.98 8
Eisai Inc. $132.53 7
Merck Sharp & Dohme Corporation $124.94 7
AbbVie Inc. $121.25 9
GlaxoSmithKline, LLC. $116.11 7
Daiichi Sankyo Inc. $109.30 6
E.R. Squibb & Sons, L.L.C. $94.50 7
Genentech USA, Inc. $90.64 5
Janssen Biotech, Inc. $84.12 5
PFIZER INC. $79.06 7
Incyte Corporation $73.14 4
Exelixis Inc. $72.21 4
Alexion Pharmaceuticals, Inc. $69.41 5
Pharmacyclics LLC, An AbbVie Company $66.59 4
GENZYME CORPORATION $64.53 3
Celgene Corporation $64.06 4
Bayer HealthCare Pharmaceuticals Inc. $55.56 3
Dova Pharmaceuticals $43.05 2
Novocure Inc. $38.42 2
Blueprint Medicines Corporation $36.93 2
Pharmacosmos Therapeutics Inc. $33.13 2
Karyopharm Therapeutics Inc. $33.09 2
ARRAY BIOPHARMA INC $32.83 2
Myriad Genetic Laboratories, Inc. $30.85 2
Gilead Sciences, Inc. $30.35 2
Kite Pharma, Inc. $28.10 2
Myovant Sciences Inc. $28.04 2
Epizyme, Inc., $22.51 1
BeiGene USA, Inc. $20.84 1
Aveo Pharmaceuticals, Inc. $19.65 1
Ipsen Biopharmaceuticals, Inc $19.31 1
Deciphera Pharmaceuticals Inc. $19.20 1
PUMA BIOTECHNOLOGY, INC. $18.23 1
EMD Serono, Inc. $17.31 1
Astellas Pharma US Inc $16.50 1
Regeneron Healthcare Solutions, Inc. $16.28 1
Rigel Pharmaceuticals, Inc. $16.08 1
JAZZ PHARMACEUTICALS INC. $15.28 1
Lilly USA, LLC $15.22 1
Taiho Oncology, Inc. $14.94 1

Page 2 of 4; records 51–100 of 171 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHRISTOPHER G WANG

NPI 1083856157 · CMS profile ID 1304108

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

BIRMINGHAM, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 171 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1083856157?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHRISTOPHER G WANG, NPI 1083856157, CMS profile ID 1304108. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 171 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1083856157?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). CHRISTOPHER G WANG, NPI 1083856157, CMS profile ID 1304108. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 171 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1083856157?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
CHRISTOPHER G WANG, NPI 1083856157, CMS profile ID 1304108, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 171 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1083856157?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

171 matching records · $4,641.31 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 171 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 171.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Amgen Inc. $19.6909/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826313649 CMS
Novartis Pharmaceuticals Corporation $13.1609/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813348593 CMS
Genentech USA, Inc. $18.0709/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835897125 CMS
Novartis Pharmaceuticals Corporation $21.0409/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813348589 CMS
GlaxoSmithKline, LLC. $18.9709/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803050247 CMS
Celgene Corporation $18.5609/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783721557 CMS
Pharmacyclics LLC, An AbbVie Company $22.7109/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 781016049 CMS
Epizyme, Inc., $22.5109/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832343401 CMS
Merck Sharp & Dohme Corporation $18.1409/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848486345 CMS
Incyte Corporation $18.4109/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835553159 CMS
Eisai Inc. $24.2408/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 817986521 CMS
Amgen Inc. $14.5308/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826313657 CMS
EMD Serono, Inc. $17.3108/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849204981 CMS
Merck Sharp & Dohme Corporation $19.6208/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848437723 CMS
Daiichi Sankyo Inc. $20.9808/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 836309483 CMS
Daiichi Sankyo Inc. $19.5008/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 836312293 CMS
Amgen Inc. $16.5008/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825222795 CMS
AbbVie Inc. $1.7308/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 796223511 CMS
AbbVie Inc. $16.2008/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 796223513 CMS
Novartis Pharmaceuticals Corporation $18.7408/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813348585 CMS
E.R. Squibb & Sons, L.L.C. $16.7308/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783617141 CMS
E.R. Squibb & Sons, L.L.C. $0.5608/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783617143 CMS
Merck Sharp & Dohme Corporation $22.2808/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848485731 CMS
Takeda Pharmaceuticals U.S.A., Inc. $29.1308/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 820325981 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1.9108/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 820325985 CMS
AbbVie Inc. $28.7808/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 796223509 CMS
AstraZeneca Pharmaceuticals LP $11.6608/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829996203 CMS
Seagen Inc. $17.2207/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832177401 CMS
Seagen Inc. $0.8507/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832177404 CMS
Incyte Corporation $24.0007/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835553147 CMS
GlaxoSmithKline, LLC. $13.1107/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802100415 CMS
Myovant Sciences Inc. $14.6207/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834995587 CMS
Exelixis Inc. $21.8907/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838869761 CMS
Amgen Inc. $16.2707/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826313645 CMS
Genentech USA, Inc. $18.7907/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835897131 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.2207/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 820325977 CMS
Janssen Biotech, Inc. $16.0507/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 787693317 CMS
Merck Sharp & Dohme Corporation $15.1007/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848437979 CMS
Merck Sharp & Dohme Corporation $10.8707/14/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848532933 CMS
Merck Sharp & Dohme Corporation $24.2107/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848505093 CMS
Rigel Pharmaceuticals, Inc. $16.0807/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 854326597 CMS
Janssen Biotech, Inc. $14.9907/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 787693335 CMS
Novartis Pharmaceuticals Corporation $21.4607/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813348581 CMS
Seagen Inc. $25.0407/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832177389 CMS
PFIZER INC. $14.7406/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832557959 CMS
Novocure Inc. $17.4006/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 823636323 CMS
Regeneron Healthcare Solutions, Inc. $16.2806/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 809634363 CMS
PUMA BIOTECHNOLOGY, INC. $18.2306/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834087633 CMS
AbbVie Inc. $4.2606/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 796223507 CMS
Celgene Corporation $11.4706/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783721523 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,993.73 189
PY2020 $1,906.86 125
PY2021 $4,641.31 171
PY2022 $2,891.96 161
PY2023 $2,694.40 141
PY2024 $3,572.99 187
PY2025 $3,313.28 162

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $24,147.35 6
PY2024 Principal investigator $5,053.64 3
PY2023 Principal investigator $89,712.52 4
PY2021 Principal investigator $282.50 1
PY2020 Principal investigator $30.40 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

6 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 PFIZER INC. $680.00 12/09/2025 Non-covered Recipient Entity
Alabama Oncology
A RANDOMIZED PHASE 3 OPENLABEL STUDY TO EVALUATE PF08046054SGNPDL1V VERSUS DOCETAXEL IN ADULT PARTICIPANTS WITH PREVIOUSLYTREATED PROGRAMMED CELL DEATH LIGAND 1 PDL1 POSITIVE NONSMALLCELL LUNG CANCER NSCLC No dispute reported 06/30/2026 1228715935
Principal investigator 1 PFIZER INC. $680.00 12/09/2025 Non-covered Recipient Entity
Alabama Oncology
A RANDOMIZED PHASE 3 OPENLABEL STUDY TO EVALUATE PF08046054SGNPDL1V VERSUS DOCETAXEL IN ADULT PARTICIPANTS WITH PREVIOUSLYTREATED PROGRAMMED CELL DEATH LIGAND 1 PDL1 POSITIVE NONSMALLCELL LUNG CANCER NSCLC No dispute reported 06/30/2026 1228715937
Principal investigator 1 PFIZER INC. $2,750.00 11/27/2025 Non-covered Recipient Entity
ALABAMA ONCOLOGY
A RANDOMIZED PHASE 3 OPENLABEL STUDY TO EVALUATE PF08046054SGNPDL1V VERSUS DOCETAXEL IN ADULT PARTICIPANTS WITH PREVIOUSLYTREATED PROGRAMMED CELL DEATH LIGAND 1 PDL1 POSITIVE NONSMALLCELL LUNG CANCER NSCLC No dispute reported 06/30/2026 1228733844
Principal investigator 1 PFIZER INC. $12,679.00 08/11/2025 Non-covered Recipient Entity
ALABAMA ONCOLOGY
A RANDOMIZED PHASE 3 OPENLABEL STUDY TO EVALUATE SGNB6A COMPARED WITH DOCETAXEL IN ADULT SUBJECTS WITH PREVIOUSLY TREATED NONSMALL CELL LUNG CANCER No dispute reported 06/30/2026 1228766781
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $1,400.00 06/18/2025 Non-covered Recipient Entity
Birmingham Hematology And Oncology Ass,llc
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE) No dispute reported 06/30/2026 1235998600
Principal investigator 1 Mirati Therapeutics, Inc. $5,958.35 04/28/2025 Non-covered Recipient Entity
Birmingham Hematology And Oncology Ass,llc
A Randomized Phase 3 Study of MRTX849 in Combination With Cetuximab Versus Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation With Disease Progression On or After Standard First-Line Therapy No dispute reported 06/30/2026 1236531248